Article
Use of a Novel Enhanced DNA Vaccine Vector for Preclinical Virus Vaccine Investigation
2019-05-27
Abstract excerpt
DNA vaccines are stable, safe, cost effective to produce and relatively quick and easy to manufacture. However, to date DNA vaccines have shown relatively poor immunogenicity in humans despite promising preclinical results. Consequently, a number of different approaches have been investigated to improve the immunogenicity of DNA vaccines. These include the use of improved delivery methods, adjuvants, stronger prom...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- e65504df-94a6-593d-801a-7e12321a64c6
- DOI
- 10.20944/preprints201905.0310.v1
